UK Gene Therapy Breakthrough Slows Huntington's Disease Progression by 75%
UK doctors have reported a breakthrough in treating Huntington's disease, with a new gene therapy able to slow its progression by 75 percent.
ScienceGNGV Editorial Team5 min readLast reviewed September 28, 2026
In one of the most significant neuroscience breakthroughs of 2025, UK doctors have reported that a new gene therapy can slow the progression of Huntington's disease by an extraordinary 75 percent. This represents a transformative moment for patients and families affected by this cruel neurodegenerative condition, which gradually destroys nerve cells in the brain and has long been considered untreatable.
Huntington's disease is caused by a mutation in the HTT gene, which produces a toxic form of the huntingtin protein. This protein accumulates in brain cells over time, leading to progressive cognitive decline, involuntary movements, and psychiatric symptoms. Until now, treatments could only manage symptoms — not address the underlying cause.
Delivered directly to the brain through a one-time procedure, the treatment has shown remarkable results in clinical trials, with patients experiencing a dramatic slowing of disease progression.
For people living with Huntington's disease, this development offers something previously unimaginable: real hope. Because Huntington's is hereditary, each child of a parent with the condition has a 50% chance of inheriting it, meaning the impact of this therapy extends across generations.
The research team has described the results as "beyond what we dared hope for." While the therapy does not yet constitute a cure, slowing the disease by 75% could mean years of additional quality life for patients.
